Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/508968]Researchers: A/Pr Phillip Darcy (Principal investigator) , A/Pr Michael Kershaw
Brief description Killer T lymphocytes can penetrate tumors and their transfer into cancer patients has demonstrated some encouraging results, but this form of immunotherapy remain ineffective in most cancer patients. We propose to improve the tumor trafficking and anti-tumor activities of killer cells by genetically engineering them with proteins that will enable them to recognise and destroy cancer cells. The outcomes of this project will validate this novel approach for treatment of cancer patients.
Funding Amount $AUD 468,119.08
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 508968
- PURL : https://purl.org/au-research/grants/nhmrc/508968
